# Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

Study · id `cardio:ct-nct07604922` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07604922](<https://clinicaltrials.gov/study/NCT07604922>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07604922

Browse, organ or system: Blood vessels; Kidneys; Metabolism  
Browse, condition area: High blood pressure; Diabetes and metabolic disease; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 165 participants.

## Technical summary

Registry record NCT07604922. Non-randomized; no masking; primary purpose basic science. Start 2026-09-17 (actual); primary completion 2028-03-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose basic science
- Phase: Not applicable
- Enrolled: 165 participants (planned count; ClinicalTrials.gov record NCT07604922, source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)
- Started: 2026-09-17 (actual) (ClinicalTrials.gov record NCT07604922, source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2028-03-15 (anticipated) (ClinicalTrials.gov record NCT07604922, source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)
- Completion: 2028-09-15 (anticipated) (ClinicalTrials.gov record NCT07604922, source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT07604922, source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07604922-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
- Acronym: STIMULUS-CKD
- Condition: Chronic Kidney Disease
- Condition: Hypertension (HTN)
- Condition: Type 2 Diabetes Mellitus (T2DM)
- Intervention (Device): HEMI device
- Intervention (Device): SPG-NINOX device
- Lead sponsor: Institut National de la Santé Et de la Recherche Médicale, France
- Lead sponsor class: OTHER\_GOV
- Collaborator: University of Turku
- Collaborator class: OTHER
- Collaborator: Imec
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Institut National de la Santé Et de la Recherche Médicale, France (`cardio:org-institut-national-de-la-sante-et-de-la-recherche-medicale-3ba447`)

## Provenance

Content hash: 9dd73943e48390b3831d710e740ad0dab662cbb86d06308f237ce2d935fe47fb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
